XML 87 R77.htm IDEA: XBRL DOCUMENT v3.24.3
Stockholders' Equity (Details) - USD ($)
$ / shares in Units, $ in Millions
3 Months Ended 9 Months Ended
Oct. 31, 2024
Jul. 31, 2024
Apr. 30, 2024
Oct. 31, 2023
Jul. 31, 2023
Apr. 30, 2023
Oct. 31, 2024
Oct. 31, 2023
Nov. 30, 2024
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Beginning balance $ 2,474 $ 2,161 $ 1,855 $ 1,206 $ 897 $ 1,145 $ 1,855 $ 1,145  
Common shares issued under stock plans 13 (38) (62) 27 (31) (21)      
Stock-based compensation expense 184 170 151 179 195 160      
Settlement of liability-classified restricted common shares     3   8 1 3 9  
Net income 275 282 252 241 222 161 809 624  
Other comprehensive (loss) income (11) 14 (29) (59) 2 (15) (26) (72)  
Repurchase and retirement of common shares (319) (115) (9) (112) (87) (534)      
Ending balance $ 2,616 $ 2,474 $ 2,161 $ 1,482 $ 1,206 $ 897 $ 2,616 $ 1,482  
Common Stock Repurchase Program                  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Common stock repurchased and retired (in shares) 1,190,000     543,000     1,694,000 4,000,000  
Repurchased shares of its common stock on the open market, average repurchase price per share (in usd per share) $ 269.30     $ 205.70     $ 262.15 $ 200.35  
November 2022 Common Stock Repurchase Program                  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Amount remained available for repurchase under repurchase plans $ 4,300     $ 4,800     $ 4,300 $ 4,800  
September 2016 Common Stock Repurchase Program                  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Shares remained available for repurchase under repurchase plans (in shares)       0       0  
Subsequent Event | November 2022 Common Stock Repurchase Program                  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Amount remained available for repurchase under repurchase plans                 $ 4,300
Subsequent Event | November 2024 Common Stock Repurchase Program                  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Stock repurchase authorized amount                 $ 5,000
Common stock and additional paid-in capital                  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Beginning balance (in shares) 215,000,000 215,000,000 214,000,000 214,000,000 214,000,000 215,000,000 214,000,000 215,000,000  
Beginning balance $ 4,009 $ 3,894 $ 3,802 $ 3,531 $ 3,368 $ 3,325 $ 3,802 $ 3,325  
Common shares issued under stock plans (in shares) 1,000,000   1,000,000 1,000,000   2,000,000      
Common shares issued under stock plans $ 13 (38) $ (62) $ 27 (31) $ (21)      
Stock-based compensation expense $ 184 170 151 $ 179 195 160      
Settlement of liability-classified restricted common shares     $ 3   8 $ 1      
Repurchase and retirement of common shares (in shares) (1,000,000)     (1,000,000)   (3,000,000)      
Repurchase and retirement of common shares $ (106) $ (17)   $ (59) $ (9) $ (97)      
Ending balance (in shares) 215,000,000 215,000,000 215,000,000 214,000,000 214,000,000 214,000,000 215,000,000 214,000,000  
Ending balance $ 4,100 $ 4,009 $ 3,894 $ 3,678 $ 3,531 $ 3,368 $ 4,100 $ 3,678  
Accumulated other comprehensive loss                  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Beginning balance (249) (263) (234) (198) (200) (185) (234) (185)  
Other comprehensive (loss) income (11) 14 (29) (59) 2 (15)      
Ending balance (260) (249) (263) (257) (198) (200) (260) (257)  
Accumulated deficit                  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Beginning balance (1,286) (1,470) (1,713) (2,127) (2,271) (1,995) (1,713) (1,995)  
Net income 275 282 252 241 222 161      
Repurchase and retirement of common shares (213) (98) (9) (53) (78) (437)      
Ending balance $ (1,224) $ (1,286) $ (1,470) $ (1,939) $ (2,127) $ (2,271) $ (1,224) $ (1,939)